Research Overview
HGH Frag (176-191) is a synthetic peptide corresponding to the C-terminal fragment of human growth hormone, studied in research models involving lipid metabolism, adipocyte biology, energy homeostasis, metabolic signaling, and body composition.
Derived from amino acids 176-191 of the human growth hormone molecule, this peptide has become an important research tool for investigating metabolic pathways associated with fat metabolism while remaining structurally distinct from full-length growth hormone. Its targeted biological profile has generated significant interest in experimental models of metabolic regulation.
Lyophilized Vial Format
Precision-manufactured and lyophilized for stability, this research-grade peptide is produced to support reproducible laboratory workflows requiring accurate preparation, controlled storage, and consistent experimental performance.
Why Researchers Study HGH Frag (176-191)
HGH Frag (176-191) is investigated for its interaction with biological pathways involved in lipid metabolism and adipocyte function. Researchers continue to examine how this peptide fragment influences metabolic signaling, cellular energy utilization, and the molecular mechanisms that regulate fat metabolism independent of the broader physiological activities associated with intact growth hormone.
Its selective mechanism has established HGH Frag (176-191) as a valuable research peptide for exploring metabolic physiology, adipose tissue biology, energy regulation, and the complex signaling networks that govern body composition.
Research Applications
Researchers commonly utilize HGH Frag (176-191) in laboratory investigations involving:
- Lipid metabolism
- Adipocyte biology
- Fat metabolism
- Energy homeostasis
- Metabolic signaling
- Cellular bioenergetics
- Body composition research
- Growth hormone fragment biology
- Metabolic adaptation
- Experimental metabolic disease models
